Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience
Open Access
- 1 September 2023
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 130 (11) , 1475-1484
Abstract
Subcutaneous apomorphine infusion is a device-aided therapy for Parkinson’s disease that can be considered when motor fluctuations become persistent and are no longer adequately controlled by oral/transdermal medication. Apomorphine infusion is less invasive than enteral levodopa, deep brain stimulation or focused ultrasound, and is often indicated even when neurosurgical approaches are contraindicated. This article aims to provide practical guidance for doctors and nurses initiating and treating patients with apomorphine infusion, and is based on both trial data and clinical experience from movement disorders specialists. A post hoc analysis of data from the TOLEDO randomized clinical trial of apomorphine infusion was conducted along with an analysis of ‘real world’ experience from 13 movement disorders specialists using a questionnaire that focused on starting patients on apomorphine infusion. Practical guidelines for starting treatment with apomorphine infusion are provided taking into consideration the regional disparities in healthcare. Apomorphine infusion is straightforward to administer but to be successful it requires concordance from the patient and family, and clinical support from an experienced team of doctors and nurses, particularly in the early months of treatment.Keywords
This publication has 30 references indexed in Scilit:
- Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's diseaseBritish Journal of Clinical Pharmacology, 2016
- Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort studyJournal of Neurology, 2016
- Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patientsParkinsonism & Related Disorders, 2016
- Infusion Therapies and Development of Impulse Control Disorders in Advanced Parkinson DiseaseClinical Neuropharmacology, 2015
- Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptorsSynapse, 2015
- Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinationsParkinsonism & Related Disorders, 2010
- Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter studyMovement Disorders, 2008
- Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challengesMovement Disorders, 2004
- Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long‐term follow‐up study of 64 patientsMovement Disorders, 2002
- Apomorphine: An underutilized therapy for Parkinson's diseaseMovement Disorders, 2000